Blood Content of the Bergen A4 Mouse Ascites Carcinoma
Author Information
Author(s): F. Hartveit
Primary Institution: The University of Bergen, School of Medicine, The Gade Institute, Department of Pathology
Hypothesis
Does the blood that appears in response to the injection of the Ehrlich ascites carcinoma reflect a response to the tumor or to genetically different tissue?
Conclusion
The study suggests that the blood content in the ascitic tumor may be related to a tumor-specific antigen and the host's inflammatory response.
Supporting Evidence
- The blood content of the tumor varied among the mice.
- There was a statistically significant negative correlation between the tumor blood content and the host's survival time.
- The study found no sex differences in tumor growth rates.
Takeaway
When mice were injected with a specific type of tumor, some developed a lot of blood in their tumors, which might be due to their body's reaction to the tumor.
Methodology
Mice were injected with a tumor suspension, and their survival and tumor growth were monitored.
Potential Biases
Potential bias in tumor cell dosage between male and female mice.
Limitations
The study could not determine the exact cause of the hemorrhagic response due to genetic compatibility.
Participant Demographics
Mice of strain A/Sn, aged 4 to 6 months.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website